News >

Chemoimmunotherapy Emerges as Frontline Standard in Squamous NSCLC

Brandon Scalea
Published: Thursday, Apr 25, 2019

Eric S. Nadler, MD

Eric S. Nadler, MD

Chemoimmunotherapy has emerged as the frontline standard of care in patients with squamous non–small cell lung cancer (NSCLC), but work still needs to be done by way of determining effective biomarkers and identifying other effective combinations, said Eric S. Nadler, MD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: How Can We Optimize Outcomes in Head and Neck Cancers with Immunotherapeutic Strategies?Oct 31, 20191.5
The Patient and Provider Connection™: Effective Communication to Optimize the Diagnosis and Management of Irritable Bowel Syndrome and Chronic Idiopathic ConstipationOct 31, 20191.0
Publication Bottom Border
Border Publication
x